Selank vs Semax: Comparative Heptapeptide Chemistry, BDNF Upregulation, and GABAergic Modulation
A structural and pharmacological comparison of Russian-developed regulatory heptapeptides: Semax (ACTH 4-10 analogue) vs Selank (Tuftsin analogue). Molecular pathways and stability. Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is derived from the N-terminal ACTH(4-10) sequence stabilized with a C-terminal Pro-Gly-Pro tripeptide.
- Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is derived from the N-terminal ACTH(4-10) sequence stabilized with a C-terminal Pro-Gly-Pro tripeptide.
- Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is derived from the endogenous immunomodulatory tetrapeptide Tuftsin, also stabilized with Pro-Gly-Pro.
- The C-terminal Pro-Gly-Pro extension protects both heptapeptides from rapid serum carboxypeptidase cleavage.
- Semax primarily stimulates BDNF/TrkB expression and dopaminergic/serotonergic neurotransmission for cognitive focus and neuroprotection.
- Selank acts as an allosteric modulator of GABAA receptors and regulates enkephalin-degrading enzymes for anxiolytic activity without sedation.
| CAS Registry Number | 129954-34-3 (Selank) / 80714-61-0 (Semax) |
|---|---|
| Molecular Formula | C33H57N11O9 / C37H51N9O10S |
| Molecular Mass | 751.87 g/mol / 813.92 g/mol |
| Primary Biological Target | BDNF/TrkB Signaling, Dopaminergic & GABAergic Systems |
| Analytical Purity Standard | ≥99.0% (RP-HPLC, C18, 214/220 nm) |
| Identity Verification | ESI-MS (±0.1 Da) + Karl Fischer Moisture (<3.0%) |
| Lyophilized Storage | -20°C desiccated, protected from UV light (24–36 months) |
| Reconstituted Storage | 2°C–8°C refrigerated (up to 28 days in 0.9% BA BAC water) |
1. Rational Design: The Pro-Gly-Pro (PGP) Stabilization Tripeptide
Both Semax and Selank were engineered at the Institute of Molecular Genetics of the Russian Academy of Sciences. Native ACTH(4-10) and Tuftsin have half-lives of less than two minutes in bloodstream due to rapid exopeptidase degradation. By appending a synthetic Pro-Gly-Pro (PGP) tripeptide to their C-termini, researchers created stable heptapeptides that resist enzymatic degradation, extending biological activity to several hours.
2. Semax: Neurotrophin Upregulation and Dopamine Modulation
Semax (MEHFPGP) acts as a powerful neuroprotective and cognitive-enhancing peptide. In brain tissue models, Semax rapidly upregulates Brain-Derived Neurotrophic Factor (BDNF) and its high-affinity receptor TrkB in the hippocampus and cortex. It activates the serotonergic and dopaminergic systems, promoting sustained alertness, synaptic plasticity, and resistance to ischemic hypoxia.
3. Selank: Allosteric GABA Modulation and Enkephalinase Inhibition
Selank (TKPRPGP) combines nootropic and anxiolytic properties. Unlike classical benzodiazepines, Selank does not bind the benzodiazepine site of GABAA receptors; instead, it acts as an allosteric modulator that normalizes GABAergic gene expression during stress. In addition, Selank inhibits enkephalin-degrading enzymes in blood plasma, elevating endogenous enkephalin levels and dampening anxiety responses.
4. Laboratory Handling and Reconstitution
Both peptides are highly soluble in sterile water and bacteriostatic saline. Because Semax contains an N-terminal methionine and histidine, avoid exposure to direct light or heavy metals to prevent oxidation. Store lyophilized powder at -20°C; maintain reconstituted solutions at 2°C to 8°C.
5. Bench Preparation & Assay Reproducibility for Selank vs Semax
When designing in-vitro experiments targeting BDNF/TrkB Signaling, Dopaminergic & GABAergic Systems, normalize dosing across replicates by molar concentration (µM or nM) using the published molecular weight (751.87 g/mol / 813.92 g/mol) and batch counterion composition rather than gross powder weight alone. Log lot numbers, diluent pH, and aliquot dates to ensure batch-to-batch reproducibility across longitudinal experiments.
Peer-Reviewed References & Analytical Standards
- Dolotov O.V. et al. (2006). Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Research, 1117(1), 54–60. [PMID: 16996037 ↗]
- Volkova A. et al. (2016). Selank administration affects the expression of some genes involved in GABAergic neurotransmission. Frontiers in Pharmacology, 7, 31. [PMID: 26924985 ↗]
Referenced Laboratory Research Reagents
Batch-verified SwissLab catalog entries cited in this monograph
All analytical monographs and chemical data are published strictly for in-vitro laboratory research and scientific reference. Reagents must be handled by qualified personnel wearing appropriate PPE. Not for human or veterinary use.